Order Article Reprints

Pettinella F, Lattanzi C, Donini M, Caveggion E, Marini O, Iannoto G, Costa S, Zenaro E, Fortunato TM, Gasperini S, et al. Plasmacytoid Dendritic Cell, Slan⁺-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients. Cancers. 2023; 15(21):5285. https://doi.org/10.3390/cancers15215285

Pettinella, Francesca, Chiara Lattanzi, Marta Donini, Elena Caveggion, Olivia Marini, Giulia Iannoto, Sara Costa, Elena Zenaro, Tiago Moderno Fortunato, Sara Gasperini, and et al. 2023. "Plasmacytoid Dendritic Cell, Slan⁺-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients" Cancers 15, no. 21: 5285. https://doi.org/10.3390/cancers15215285

Pettinella, F., Lattanzi, C., Donini, M., Caveggion, E., Marini, O., Iannoto, G., Costa, S., Zenaro, E., Fortunato, T. M., Gasperini, S., Giani, M., Belluomini, L., Sposito, M., Insolda, J., Scaglione, I. M., Milella, M., Adamo, A., Poffe, O., Bronte, V., ... Scapini, P. (2023). Plasmacytoid Dendritic Cell, Slan⁺-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients. Cancers, 15(21), 5285. https://doi.org/10.3390/cancers15215285